| 今开：3.2 | 昨收：3.2 |
| 最高：3.28 | 最低：3.1 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：8.1431476E7 |
Leap Therapeutics(LPTX)02-01 10:45
$Leap Therapeutics(LPTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-009026 Size: 5 KB 网页链接查看全文
Leap Therapeutics(LPTX)01-31 09:45
$Leap Therapeutics(LPTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-008417 Size: 9 KB 网页链接查看全文
Leap Therapeutics(LPTX)01-31 09:45
$Leap Therapeutics(LPTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-008421 Size: 9 KB 网页链接查看全文
Leap Therapeutics(LPTX)01-27 06:25
$Leap Therapeutics(LPTX)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001104659-24-007336 Act: 33 Size: 65 KB 网页链接查看全文
Leap Therapeutics(LPTX)02-01 10:35
$Leap Therapeutics(LPTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-009021 Size: 5 KB 网页链接查看全文
Leap Therapeutics(LPTX)02-01 10:45
$Leap Therapeutics(LPTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-009024 Size: 5 KB 网页链接查看全文
Leap Therapeutics(LPTX)03-18 19:45
$Leap Therapeutics(LPTX)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001104659-24-035255 Act: 33 Size: 507 KB 网页链接查看全文
Leap Therapeutics(LPTX)03-18 18:55
$Leap Therapeutics(LPTX)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001410578-24-000218 Act: 34 Size: 8 MB 网页链接查看全文
Leap Therapeutics(LPTX)04-20 04:35
$Leap Therapeutics(LPTX)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001062993-24-008602 Size: 4 KB 网页链接查看全文
Leap Therapeutics(LPTX)02-01 10:35
$Leap Therapeutics(LPTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-009017 Size: 5 KB 网页链接查看全文
令狐不冲9992021-09-16 21:11
2021年9月16日盘前异动： $Alset EHome(AEI)$ $Leap Therapeutics(LPTX)$ $WISeKey(WKEY)$查看全文
可以取个啥名字2021-09-15 08:03
$百济神州(BGNE)$ $百济神州(06160)$ $Leap Therapeutics(LPTX)$ DKK+Tisle，虽然入组人数较少，但是这惊人的药效值得快速推进了查看全文
chuminhua2021-09-14 10:20
9月13日，Leap Therapeutics公司的股票周一上涨了近29%，此前该公司表示，其DKK1抗体DKN-01与BeiGene公司的抗PD-1抗体tislelizumab联合进行的IIa期研究在胃癌或胃食管结节癌（G/GEJ）一线患者中产生了 "引人注目的活性"。DisTinGuish研究的结果将在本周的欧洲医学肿瘤学会（ESMO）会议上详...查看全文
产业链观察2021-09-13 19:42
药闻▶2021 年 9 月 13 日，专注于开发靶向和免疫肿瘤疗法的生物技术公司$Leap Therapeutics(LPTX)$ ，今天宣布该公司将提供来自DisTinGuish 研究一项 2a 期临床试验一线队列的初步数据，评估 Leap 的抗 Dickkopf-1 (DKK1) 抗体 DKN-01 与$百济神州(06160)$ tislelizumab的抗 PD-1 抗...查看全文
$Leap Therapeutics(LPTX)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001062993-24-008602 Size: 4 KB 网页链接
$Leap Therapeutics(LPTX)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-24-102955 Act: 34 Size: 41 KB 网页链接
$Leap Therapeutics(LPTX)$ 8-K Current report, items 1.01, 3.02, 8.01, and 9.01 Accession Number: 0001104659-24-046108 Act: 34 Size: 7 MB 网页链接
$Leap Therapeutics(LPTX)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001104659-24-035255 Act: 33 Size: 507 KB 网页链接
$Leap Therapeutics(LPTX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001104659-24-035239 Act: 34 Size: 319 KB 网页链接
$Leap Therapeutics(LPTX)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001410578-24-000218 Act: 34 Size: 8 MB 网页链接
$Leap Therapeutics(LPTX)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-24-036392 Act: 34 Size: 64 KB 网页链接
$Leap Therapeutics(LPTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-009025 Size: 5 KB 网页链接
$Leap Therapeutics(LPTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-009029 Size: 5 KB 网页链接
$Leap Therapeutics(LPTX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-009031 Size: 5 KB 网页链接